共 53 条
A Small-Molecule Inhibitor of BCL6 Kills DLBCL Cells In Vitro and In Vivo
被引:235
作者:
Cerchietti, Leandro C.
[2
,5
]
Ghetu, Alexandru F.
[3
,4
]
Zhu, Xiao
[1
]
Da Silva, Gustavo F.
[6
]
Zhong, Shijun
[1
]
Matthews, Marilyn
[1
]
Bunting, Karen L.
[2
,5
]
Polo, Jose M.
[6
]
Fares, Christophe
[3
,4
]
Arrowsmith, Cheryl H.
[3
,4
,7
]
Yang, Shao Ning
[2
,5
]
Garcia, Monica
[2
,5
]
Coop, Andrew
[1
]
MacKerell, Alexander D., Jr.
[1
]
Prive, Gilbert G.
[3
,4
,7
,8
]
Melnick, Ari
[2
,5
]
机构:
[1] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA
[2] Cornell Univ, Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA
[3] Ontario Canc Inst, Toronto, ON M5G 1L7, Canada
[4] Campbell Family Inst Canc Res, Toronto, ON M5G 1L7, Canada
[5] Cornell Univ, Weill Cornell Med Coll, Div Hematol & Med Oncol, Dept Med, New York, NY 10065 USA
[6] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA
[7] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2N9, Canada
[8] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada
来源:
关键词:
GERMINAL-CENTER FORMATION;
BTB DOMAIN;
EXPRESSION;
PHARMACOKINETICS;
IDENTIFICATION;
DOCKING;
COREPRESSOR;
MODEL;
AZITHROMYCIN;
PATHOGENESIS;
D O I:
10.1016/j.ccr.2009.12.050
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
The BCL6 transcriptional repressor is the most frequently involved oncogene in diffuse large B cell lymphoma (DLBCL). We combined computer-aided drug design with functional assays to identify low-molecular-weight compounds that bind to the corepressor binding groove of the BCL6 BTB domain. One such compound disrupted BCL6/corepressor complexes in vitro and in vivo, and was observed by X-ray crystallography and NMR to bind the critical site within the BIB groove. This compound could induce expression of BCL6 target genes and kill BCL6-positive DLBCL cell lines. In xenotransplantation experiments, the compound was nontoxic and potently suppressed DLBCL tumors in vivo. The compound also killed primary DLBCLs from human patients.
引用
收藏
页码:400 / 411
页数:12
相关论文